The company said revenue for the Q2 2025 quarter, ended June 30 3 months, was $6,430 million ($5,402 million a year earlier), and income from operations was $1,151 million ($1,009 million a year earlier).

1. 01

   The company said revenue for the Q2 2025 quarter, ended June 30 3 months, was $6,430 million ($5,402 million a year earlier), and income from operations was $1,151 million ($1,009 million a year earlier).

2. 02

   WM said total company revenue rose 19.0% in Q2 2025, and WM Legacy Business revenue rose 7.1%. Revenue at WM Healthcare Solutions was $646 million.

3. 03

   WM said net cash provided by operating activities for the first six months of 2025 was $2.75 billion, and free cash flow was $1.29 billion. It said the operating cash flow reflected higher cash interest, mainly related to funding the Stericycle acquisition.

4. 04

   The company kept its 2025 adjusted operating EBITDA guidance midpoint at $7.550 billion and narrowed the range to $7.475 to $7.625 billion. It said free cash flow is now expected to be between $2.8 and $2.9 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.